Belarusian-Dutch joint enterprise "Farmland" plans to fully meet the demand of Belarus in pharmaceuticals from human plasma and replace imported analogues. BelTA was informed in the company.
According to Deputy General Director of JV "Farmland" for Research and Innovation Vadim Senchuk, from blood plasma is planned to make such vital for human drugs, like albumin, intravenous immunoglobulin and coagulation factors VIII and IX, used to treat cancer, cardiac, neurological diseases.
The new plant was built under the investment agreement signed in 2013 and now Belarus represented by the Ministry of Health. The latter is committed to delivering an annual 100 thousand. Liters of blood plasma of the existing stations of blood transfusion. At the same time, the company has been able to create your own plazmotsentr. "During the processing of 150 thousand. Liters of plasma close the demand of the republic for all four drugs, but we will also export. In the future, perhaps to process 350 thousand. Liters of plasma - this is the second phase of the project - said Vadim Senchuk. - In terms of money to produce products planned for $ 35 million with the possibility of growth. In the current environment of Belarus buys these drugs at $ 23 million in foreign countries. "
Blood plasma - the object of the potential dangers of the virus, so the production is built on the principle of obligatory virus inactivation. "Farmland" is already finished construction of the new plant on its own production site in Nesvizh. Summed utilities, create a repository of frozen plasma, warehouses, completed installation of clean room systems, water treatment, purification and air-conditioning. Purchased modern equipment, including containers and reactors, pumps, flow-through ultracentrifugation, installation of various types of filtration, bottling line of sterile finished products in glass bottles and plastic containers, and more.